Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87d40fb4785f5b3f1a4dba8c69339d1a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-33 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-39 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
filingDate |
2011-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_646306cf98f24bbc4aefe7935e36b66e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7970f80b6ad1d6f3d520d0603663e2b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a188cd2a3655fd00374ce93591dbea9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f35957708a647cbecbdd5f1d251a57f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c452440f1f992e8498d3660b36c5ef45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b9130decfd5fdf6fbbb398d6a23b2b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d65f38122837c1781c1df80df3e7b121 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_384633fe7e4892dc74ab247e417d0246 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68bb91479aae129054e49d99e089d4a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_644cb854382a9a82acd462aeec30b881 |
publicationDate |
2013-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20130064662-A |
titleOfInvention |
Pharmaceutical composition comprising triterpene compounds for prevention and treatment of bone diseases |
abstract |
The present invention relates to a pharmaceutical composition for preventing and treating bone diseases containing a triterpene compound represented by the following Chemical Formula 1 as an active ingredient. Formula 1 (In Formula 1, R is a hydroxy group or a ketone group.) |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101490033-B1 |
priorityDate |
2011-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |